Evaluate the Effect of Obicetrapib in Patients With HeFH on Top of Maximum Tolerated Lipid-Modifying Therapies.

PHASE3CompletedINTERVENTIONAL
Enrollment

354

Participants

Timeline

Start Date

July 25, 2022

Primary Completion Date

May 28, 2024

Study Completion Date

May 28, 2024

Conditions
DyslipidemiasHigh CholesterolHypercholesterolemiaFamilial HypercholesterolemiaLipid Metabolism DisorderMetabolic DiseaseLipid Metabolism, Inborn ErrorsGenetic Disease, InbornHyperlipoproteinemias
Interventions
DRUG

Obicetrapib

10 mg Obicetrapib tablet

DRUG

Placebo

placebo tablet made to resemble active

Trial Locations (96)

112

Site 022003, Tbilisi

131

Site 022004, Tbilisi

144

Site 022010, Tbilisi

154

Site 018009, Centurion

157

Site 018006, Centurion

159

Site 022006, Tbilisi

Site 022007, Tbilisi

Site 022008, Tbilisi

186

Site 022002, Tbilisi

Site 022005, Tbilisi

579

Site 022009, Tbilisi

587

Site 023002, Oslo

4321

Site 018008, Umhlanga

4400

Site 018007, Tongaat

6000

Site 022001, Batumi

7130

Site 018003, Somerset West

Site 018005, Somerset West

7500

Site 018004, Parow

7530

Site 018002, Cape Town

8008

Site 023003, Bodø

8036

Site 017001, Barcelona

8208

Site 17013, Sabadell

8907

Site 17002, Barcelona

9301

Site 018001, Bloemfontein

11758

Site 01001, North Massapequa

14004

Site 17003, Córdoba

15001

Site 17004, A Coruña

15006

Site 02004, Prague

15706

Site 17015, Santiago de Compostela

17600

Site 17018, Figueras

18014

Site 17011, Granada

21007

Site 17017, Huelva

22002

Site 17012, Huesca

23434

Site 01014, Suffolk

27157

Site 01019, Winston-Salem

28034

Site 17010, Madrid

28041

Site 17016, Madrid

28655

Site 01020, Morganton

29010

Site 17007, Málaga

34230

Site 01009, Sarasota

35016

Site 17008, Las Palmas de Gran Canaria

37405

Site 01008, Chattanooga

39105

Site 01005, Port Gibson

41009

Site 17009, Seville

41013

Site 17006, Seville

46014

Site 17014, Valencia

50009

Site 17005, Zaragoza

52240

Site 01012, Iowa City

60602

Site 01018, Chicago

63130

Site 01006, St Louis

65691

Site 02006, Brno

68510

Site 01011, Lincoln

68701

Site 01004, Norfolk

70809

Site 01007, Baton Rouge

72401

Site 01022, Jonesboro

76706

Site 01013, Houston

79905

Site 01016, El Paso

83702

Site 01023, Boise

91602

Site 01015, Toluca Lake

07960

Site 01002, Morristown

07901

Site 01010, New Providence

L6Z 4N5

Site 06007, Brampton

G7H 7K9

Site 06008, Chicoutimi

B3H 3A7

Site 06005, Halifax

H2W 1R7

Site 06003, Montreal

H3A 1A1

Site 06009, Montreal

G1V 4W2

Site 06004, Québec

J1H 5N4

Site 06006, Sherbrooke

V6Z 2C7

Site 06001, Vancouver

V8T 5G4

Site 06002, Victoria

500 05

Site 02002, Hradec Králové

128 08

Site 02003, Prague

140 21

Site 02005, Prague

686 01

Site 02001, Uherské Hradiště

1105AZ

Site 04001, Amsterdam

6815 AD

Site 04003, Arnhem

7416 SE

Site 04002, Deventer

5631 BM

Site 04004, Eindhoven

4708 AE

Site 04005, Roosendaal

3015 GD

Site 04006, Rotterdam

15-276

Site 05002, Bialystok

92-213

Site 05003, Lodz

93-338

Site 05004, Lodz

41-800

Site 05005, Zabrze

22-400

Site 05001, Zamość

B21 9RY

Site 014006, Birmingham

BS2 8HW

Site 014012, Bristol

CF14 4XW

Site 014009, Cardiff

PO19 6SE

Site 014010, Chichester

DD1 9SY

Site 014001, Dundee

NW3 2QG

Site 014002, London

M23 9LT

Site 014003, Manchester

CH62 6EE

Site 014008, Metropolitan Borough of Wirral

TR19 7HU

Site 014011, Penzance

SG14AB

Site 014005, Stevenage

B71 4HJ

Site 014004, West Bromwich

Sponsors
All Listed Sponsors
lead

NewAmsterdam Pharma

INDUSTRY